Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Myeloid-derived suppressor cells as regulators of the immune system.

Gabrilovich DI, Nagaraj S.

Nat Rev Immunol. 2009 Mar;9(3):162-74. doi: 10.1038/nri2506. Review.

2.

Myeloid-derived suppressor cells: paradoxical roles in infection and immunity.

Dai J, El Gazzar M, Li GY, Moorman JP, Yao ZQ.

J Innate Immun. 2015;7(2):116-26. doi: 10.1159/000368233. Epub 2014 Nov 8. Review.

3.

Myeloid derived suppressor cells and their role in tolerance induction in cancer.

Fujimura T, Mahnke K, Enk AH.

J Dermatol Sci. 2010 Jul;59(1):1-6. doi: 10.1016/j.jdermsci.2010.05.001. Review.

PMID:
20570112
4.

Amino acid metabolism related to immune tolerance by MDSCs.

Yang B, Wang X, Ren X.

Int Rev Immunol. 2012 Jun;31(3):177-83. doi: 10.3109/08830185.2012.679989. Review.

PMID:
22587019
5.

Insights into Myeloid-Derived Suppressor Cells in Inflammatory Diseases.

Kwak Y, Kim HE, Park SG.

Arch Immunol Ther Exp (Warsz). 2015 Aug;63(4):269-85. doi: 10.1007/s00005-015-0342-1. Epub 2015 May 20. Review.

PMID:
25990434
6.

Antigen specificity of immune suppression by myeloid-derived suppressor cells.

Solito S, Bronte V, Mandruzzato S.

J Leukoc Biol. 2011 Jul;90(1):31-6. doi: 10.1189/jlb.0111021. Epub 2011 Apr 12. Review.

PMID:
21486906
7.

Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.

Parker KH, Beury DW, Ostrand-Rosenberg S.

Adv Cancer Res. 2015;128:95-139. doi: 10.1016/bs.acr.2015.04.002. Epub 2015 May 12. Review.

8.

Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.

Yu J, Du W, Yan F, Wang Y, Li H, Cao S, Yu W, Shen C, Liu J, Ren X.

J Immunol. 2013 Apr 1;190(7):3783-97. doi: 10.4049/jimmunol.1201449. Epub 2013 Feb 25.

9.

Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function.

Condamine T, Gabrilovich DI.

Trends Immunol. 2011 Jan;32(1):19-25. doi: 10.1016/j.it.2010.10.002. Epub 2010 Nov 8. Review.

10.

Myeloid-derived suppressor cells in cancer: recent progress and prospects.

Khaled YS, Ammori BJ, Elkord E.

Immunol Cell Biol. 2013 Sep;91(8):493-502. doi: 10.1038/icb.2013.29. Epub 2013 Jun 25. Review.

PMID:
23797066
11.

Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.

Marigo I, Dolcetti L, Serafini P, Zanovello P, Bronte V.

Immunol Rev. 2008 Apr;222:162-79. doi: 10.1111/j.1600-065X.2008.00602.x. Review.

PMID:
18364001
12.

Myeloid-derived suppressor cell heterogeneity in human cancers.

Solito S, Marigo I, Pinton L, Damuzzo V, Mandruzzato S, Bronte V.

Ann N Y Acad Sci. 2014 Jun;1319:47-65. doi: 10.1111/nyas.12469. Review.

PMID:
24965257
13.

Myeloid-specific expression of human lysosomal acid lipase corrects malformation and malfunction of myeloid-derived suppressor cells in lal-/- mice.

Qu P, Yan C, Blum JS, Kapur R, Du H.

J Immunol. 2011 Oct 1;187(7):3854-66. doi: 10.4049/jimmunol.1003358. Epub 2011 Sep 7.

14.

Myeloid cell population dynamics in healthy and tumor-bearing mice.

Ueha S, Shand FH, Matsushima K.

Int Immunopharmacol. 2011 Jul;11(7):783-8. doi: 10.1016/j.intimp.2011.03.003. Epub 2011 Mar 22. Review.

PMID:
21406269
15.

Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer.

Albeituni SH, Ding C, Yan J.

Cancer J. 2013 Nov-Dec;19(6):490-501. doi: 10.1097/PPO.0000000000000006. Review.

16.

Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer.

Pan PY, Ma G, Weber KJ, Ozao-Choy J, Wang G, Yin B, Divino CM, Chen SH.

Cancer Res. 2010 Jan 1;70(1):99-108. doi: 10.1158/0008-5472.CAN-09-1882. Epub 2009 Dec 8.

17.

The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells.

Lindau D, Gielen P, Kroesen M, Wesseling P, Adema GJ.

Immunology. 2013 Feb;138(2):105-15. doi: 10.1111/imm.12036. Review.

18.

Myeloid-derived suppressor cells participate in preventing graft rejection.

Wang Y, Gu X, Xiang J, Chen Z.

Clin Dev Immunol. 2012;2012:731486. doi: 10.1155/2012/731486. Epub 2012 Mar 15. Review.

19.

Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling.

Nagaraj S, Nelson A, Youn JI, Cheng P, Quiceno D, Gabrilovich DI.

Cancer Res. 2012 Feb 15;72(4):928-38. doi: 10.1158/0008-5472.CAN-11-2863. Epub 2012 Jan 11.

20.

Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion.

Höchst B, Schildberg FA, Sauerborn P, Gäbel YA, Gevensleben H, Goltz D, Heukamp LC, Türler A, Ballmaier M, Gieseke F, Müller I, Kalff J, Kurts C, Knolle PA, Diehl L.

J Hepatol. 2013 Sep;59(3):528-35. doi: 10.1016/j.jhep.2013.04.033. Epub 2013 May 9.

PMID:
23665041

Supplemental Content

Support Center